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Abstract 
AIM: The present study was undertaken to evaluate the possible protective role of thymoquinone on CCl4-
induced hepatotoxicity.  
METHODS: The activities of liver function enzymes and antioxidant enzymes were measured. Haematoxylin-
Eosin staining was performed to analyze the live tissue alterations. Additionally, expression pattern of different 
proteins was evaluated through immunohistochemistry staining. 
RESULTS: The antioxidants enzymes activities were decreased significantly in the CCl4 induced group whereas 
recovery/increase of antioxidant enzymes was observed when thymoquinone was given to the mice. Moreover, 
thymoquinone administration significantly decrease the serum levels of alanine aminotransferase (ALT), alkaline 
phosphatase (ALP), and serum aspartate aminotransferase (AST). Liver tissue alterations were noted in CCl4 
treated group whereas treatment with thymoquinone significantly prevented the CCl4-induced histological 
alteration. The expression of PTEN protein was high in CCl4 plus thymoquinone treated group while the loss of 
PTEN protein expression was observed in CCl4 treated group. Moreover, high expression of P53 protein was 
noticed in CCl4 treated the group as compared to CCl4 plus thymoquinone group. Difference in expression 
pattern of PTEN and p53 protein in CCl4 group and thymoquinone plus CCl4 treated group was statically 
significant (p < 0.05). Besides, expression of VEGF was high in CCl4 treated group as well as thymoquinone plus 
CCl4 treated group and difference in expression pattern was statically insignificant (p > 0.05).  
CONCLUSION: Our results suggest that thymoquinone can protect CCl4 induced liver damage and could be a 
preventive drug in the development of novel therapeutic agents for liver diseases. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Liver disease is one of the major global health 
problems regarding morbidity and mortality. In this 
regard, several factors including viruses and alcohol 
abuse show a role in the pathogenesis, but exact 
molecular mechanism involved in this respect is not 
fully explained. Moreover, the molecular routes causal 
the pathogenesis of acute liver injury is recognised to 
involve a complex interplay of oxidative stress, 
apoptosis, inflammation and another process [1], [2].  
Carbon tetrachloride (CCl4) is a well-known 
hepatotoxin that is usually used to induce liver injury 
in a large variety of laboratory animals [3], [4]. The 
overdoses of CCl4 either orally or intraperitoneally, 
induce hepatic damage, including loss of architecture 
of hepatocytes, inflammation, congestion, 
degeneration and necrosis. Furthermore, exposure of 
CCl4 shows role in the reactive oxygen species 
generation, which in turn decreases the antioxidant 
enzymes that show role in the detoxification of toxic 
materials. Additionally, CCl4 reduces antioxidant 
enzymes which catalyse the decomposition of 
hydrogen peroxide to water and oxygen and which 
neutralise the reactive superoxide radical activity. 
Intake of medicinal plants and its active 
component with antioxidant phytochemicals is 
confirmed to enhance the antioxidant level and inhibit 
the pathogenesis. In this view, medicinal plant or their 
constituents have proven their role in the inhibition of 
pathogenesis due to the rich source of antioxidant [5], 
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[6]. Thymoquinone is the principal component of 
Nigella sativa which is familiar as black cumin or black 
seed [7], [8] and its use in the cure of diseases, as 
well as inhibition of pathogenesis, has been 
described. Moreover, Ayurveda, Unani, Arabic and 
Chinese medicine have shown its importance in 
health management. Also, its role in cancer 
prevention has been noted through modulation of cell 
signalling pathways including angiogenesis, apoptosis 
and tumour suppressor gene [9]. However, its anti-
tumour activity has been proven as it shows role in the 
cell death and tumour growth inhibitory activities and 
has been found to be associated with other 
tumorigenic processes [10], [11].  
This study was undertaken to examine 
whether TQ protects against CCl4-induced 
hepatotoxicity in mice. 
 
 
Material and Methods 
 
This study was conducted by the guidance of 
the ethical committee for animal handling at Qassim 
University. The experimental procedure was approved 
by the Bioethics Review Committee of the College of 
Applied Medical Science, Qassim University. 
A total number of 24 young adult male albino 
mice were included in this study. The mice were 
housed in the animal house of the College of Applied 
Medical Science, Qassim University. The mice age 
was between the six and seven weeks and weighed 
between 23-28 g were included in the study. All mice 
were fed in the laboratory maintained at approximately 
22°C with a 12-h light–dark cycle with free access to 
food and water. An acclimation period of 1 week was 
employed earlier to the experiments. Animal grouping 
and treatment plan are described in Table1. 
Table 1: Grouping of animals and treatment plan 
Group 
number 
Experimental 
group 
Treatment 
Number of animal 
per group 
1 Control 
Normal mice administered with vehicle 
solution 
8 
2 Disease group CCl4 treatment group 8 
3 Treatment groups 
CCl4 (0.04 cc of a 40 per cent solution of 
CCl4) plus thymoquinone (10 mg/kg/day 
dissolved in a DMSO) treatment 
8 
 
The mice were randomly divided into 3 groups 
as follows: 
Group 1: The first group is the untreated 
control group and was administered with olive oil 
(orally by gavage twice in a week until the last day of 
the experiment) which was used as a vehicle, and fed 
normal diet and water for 12 weeks. 
Group 2: (Diseases control: CCl4 control 
group): Mice were treated with CCl4 (0.04 cc of a 40 
per cent solution of CCl4) in olive oil [12] orally by 
gavage three times in a week for 12 weeks.  
Group 3: Thymoquinone plus CCl4 treated 
group. Thymoquinone-CCL4 treated group, mice 
received thymoquinone (10 mg/kg body weight/day) 
[13] starting one week before CCl4
 
administration and 
continued throughout the experiment for 12 weeks. 
Blood samples were collected and allowed to 
clot for 30 minutes and centrifuged to separate clear 
serum. The activities of enzymes such as alanine 
aminotransferases (ALT), aspartate aminotransferase 
(AST), Alkaline phosphatase (ALP), Catalase, 
Superoxide dismutase (SOD) Glutathione peroxidase 
(GPx) and total antioxidant capacity activity was 
measured through ELISA kits, and the results were 
interpreted accordingly (Figure 1).  
 
Figure 1: Implication of thymoquinone in the prevention of liver 
damage through modulation of biological activities 
 
Liver tissues were collected from mice of each 
group and fixed in 10% buffered formalin. These 
tissues were processed through tissue processor to 
make a paraffin-embedded block. Sections were 
made from each tissue block and Hematoxylin-Eosin 
(H & E) staining was performed to analyse the live 
tissue alterations, and observation was noted under a 
light microscope. 
Expression of different types of proteins 
including PTEN, VEGF and P53 was evaluated 
through immunohistochemistry as by previously 
described method [14]. Concisely, deparaffinization of 
the sections was made through xylene and 
rehydration on each section was performed. A 
blocking agent such as hydrogen peroxidase was 
used to block the endogenous peroxidase activity 
(Abcam, USA). Furthermore, nonspecific binding was 
blocked by a protein blocking agent (Abcam, USA). 
Monoclonal antibodies of PTEN, VEGF and P53 
(Abcam, USA) were used as primary antibodies. 
Secondary antibody and tertiary antibody were used 
on each section for 90 minutes respectively. Finally, 
diaminobenzidine (DAB) step was performed on 
section according to the manufacturer’s instructions, 
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and the sections were counterstained with 
haematoxylin. The cases were considered as positive 
for each marker when more than 5% of the cells 
showed positive expression or less than 5% 
expression was considered as a negative expression.  
Terminal deoxynucleotidyl transferase-
mediated dUTP nick end-labelling was performed to 
assist in the detection of apoptotic cells in tissue 
sections. Apoptoticaly fragmented cellular DNA was 
identified by TUNEL assay according to kits guidelines 
(Apoptosis Detection Kit, Abcam, USA). 
Counterstaining with haematoxylin was made to 
evaluate and characterise the normal and apoptotic 
cells. 
All values are expressed as mean ± SD. A 
level of p ≤ 0.05 was taken as statically significant. 
Chi-square 
2
 test was used to make the correlation of 
marker with histopathological findings. 
 
 
Results 
 
Oral administration of CCl4 to mice showed 2 
(25%) mortality in CCl4 treated group (Diseases 
group), whereas no mortality was seen in the other 
groups such as control group and CCl4 plus 
thymoquinone treated group.  
 
Figure 2: Effect of thymoquinone on serum liver function enzymes 
activity. Liver function enzymes were significantly reduced in CCl4 
plus thymoquinone treated group and was high in CCL4 treated 
group (p ≤ 0.05) 
 
To study the therapeutic implication of 
thymoquinone (TQ) in liver toxicity, TQ was given to 
CCl4-induced hepatotoxicity mice. The serum of ALT, 
AST and ALP enzymes activity was measured in 
different groups, and it was noticed that ALT, AST and 
ALP activity significantly increased in the CCl4 treated 
group (Disease group) as compared to control group 
(Figure 2). Moreover, ALT, AST and ALP activity was 
significantly decreased in the group that received 
thymoquinone (CCl4 plus thymoquinone treated mice 
group) (p ≤ 0.05). This finding confirms that 
thymoquinone has a potential role in the liver 
protection through reduction of liver functions 
enzymes in CCl4 hepatotoxicity (Figure 2). 
In this study, the activity of the antioxidant 
enzymes SOD, GPx, catalase activity and total 
antioxidant capacity were significantly decreased in 
the disease control group (group 2) as compared to 
the untreated control (Group 1) (Figure 3). Moreover, 
it was observed that thymoquinone significantly 
restore the antioxidant enzyme activity (p ≤ 0.05) 
including SOD, GPx, catalase and total antioxidant 
capacity in CCl4 plus thymoquinone group as 
compared to the disease control group (CCL4 treated 
only) (Figure 3). 
 
Figure 3: Effect of thymoquinone on SOD, GPx, Catalase and total 
antioxidant capacity (T-AOC) activity. Hepatic SOD, GPx, Catalase 
and total antioxidant capacity was high in thymoquinone plus CCl4 
treated groups as compared CCL4 treated group only and this 
difference was statically significant) (p ≤ 0.05) 
 
Histopathological changes in liver tissues are 
presented in different groups of mice. The normal 
architecture of liver tissue was maintained in the 
control group (Figure 4a).  
 
Figure 4 (a-d): a: Liver histology of control group showing the 
normal architecture of hepatocytes b: CCl4 treated mice showing 
severe infiltration of inflammatory cells c: CCl4 treated mice showing 
infiltration of inflammatory cells, and blood vessel dilation d: CCl4 
plus Thymoquinone treated mice showing less inflammatory cells 
and less congestion (Orig.MagX40) 
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Different types of liver tissue alterations were 
seen in CCl4 treated group, and it was observed as 
severe congestion, infiltration of inflammatory cells, 
haemorrhages, fatty degeneration and blood vessel 
dilation (Figures 4b and c). Though these 
consequences were also noticed in the CCl4 plus 
thymoquinone group, the incidence and severity of 
alterations were less than those in CCl4 treated group 
(Figure 4d).  
 
Figure 5: a) PTEN protein expression was detected in control cases 
and intensity of expression was high; b) PTEN protein expression 
was detected in CCl4 plus thymoquinone treated group (Orig. X 
mag40); c) PTEN protein expression was detected in CCl4 treated 
group, and the intensity of expression was low; d) PTEN protein 
expression was detected in CCl4 treated group and intensity of 
expression was low (Orig. X mag40) 
 
PTEN protein expression was examined in all 
the groups of mice and results were interpreted based 
on the expressional patterns. The loss of PTEN 
protein was noticed in CCl4 treated group. The 
intensity of expression was high in the control group 
(Group 1) as well as in CCl4 plus thymoquinone 
treated group (Group 3) as compared to CCl4 treated 
group (Group 2) (Figure 5 a, b, and c).  
 
Figure 6: a) P53 protein expression was not detected in control 
cases; b) P53 protein expression was detected in CCl4 plus 
thymoquinone group but expression intensity was low; c) P53 
protein expression was detected in CCl4 group, and intensity of 
expression was high (Orig. X mag40) 
 
P53 expression was evaluated in all group of 
mice, and it was noticed that all 8 cases of the control 
group did not show any expression (Figure 6a). A 
higher expression of P53 protein was noticed in CCl4 
treated group (diseases control) (Figure 6b) as 
compared to CCl4 plus thymoquinone group (Figure 
6c). The difference in expression pattern among CCl4 
treated group and thymoquinone plus CCl4 treated 
group was statically significant (p < 0.05) 
The control group showed weak cytoplasmic 
VEGF expression (Figure7-a) whereas expression 
was high in CCl4 treated group (Figure 7-b). Moreover, 
VEGF expression was also noted in thymoquinone 
plus CCl4 treated group (Figure 7-c). The difference in 
expression pattern between CCl4 treated group and 
CCl4 plus thymoquinone treated group was statically 
insignificant (p > 0.05) 
 
Figure 7: a) Weak VEGF protein expression was noted in control 
group; b) VEGF protein expression was detected in CCl4 group; c) 
VEGF protein expression was detected in CCl4 plus thymoquinone 
group (Orig. X mag40) 
 
Apoptosis was not detected in any group 
including CCl4 treated group (Figure 8a) as well as 
CCl4 plus thymoquinone treated group (Figure 8b). 
 
Figure 8: a) Apoptosis was not detected in CCl4-treated group; b) 
Apoptosis was not detected in CCl4 plus thymoquinone treated 
group (Orig. mag×40) 
 
 
 
Discussion 
 
The prevalence of liver pathogenesis is 
comparatively increasing, and the mortality and 
morbidity rates are significantly increasing in Saudi 
Arabia [15], [16]. The current study was based on a 
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mice model performed to examine the 
hepatoprotective effects of thymoquinone in repeated 
CCl4 administration induced hepatotoxicity. CCl4-
induced acute liver injury in a murine model has been 
used for screening the hepatoprotective activities of 
drugs [17]. Thymoquinone (TQ) is an active 
constituent present in the black seed and broadly 
studied over the decades for its role in diseases cure 
without promoting any severe side effects. TQ has 
proven its role in the protection of organs against 
oxidative damage induced by a free radical generating 
agents [18]. TQ and a synthetic structurally-related 
TBHQ strongly inhibited iron-dependent microsomal 
lipid peroxidation in a concentration-dependent 
manner [19]. TQ importance has been discussed by 
earlier investigator [20], and TQ has proven role 
through modulation of diverse oncogenic transcription 
factors [21]. Moreover, another study was to 
investigate the effects of TQ on head and neck 
squamous cell carcinoma (HNSCC) cell lines. The 
result of the study revealed that TQ exhibited dose-
dependent cytotoxicity via apoptosis in the 
investigated cell lines [22]. 
In the present study, TQ treatment showed 
significant protection against CCl4-induced liver injury, 
which was noticed by the decrease of serum ALT, 
ALP and AST levels. Whereas serum activity of ALT, 
AST and ALP were significantly increased in the CCl4 
treated group (Disease control). This finding confirms 
that thymoquinone has a potential role in the liver 
protection through a reduction in liver functions 
enzymes. This result agrees with an earlier study [23] 
reported that serum ALT, AST levels, and SOD 
activity, as well as the serum and tissue MDA levels, 
were found to be higher in the acetaminophen group 
than in the control group. Whereas in the 
acetaminophen + TQ group, serum ALT, AST levels, 
SOD activity and the serum and tissue MDA levels 
were found to be lower as compared to that of the 
APAP group and such difference was statistically 
significant [23]. This result is consistent with the 
previous study, and it was reported that of exposure to 
sodium fluoride resulted in a change in liver function 
as designated by a significant increase in the activity 
of AST, ALT, ALP, LDH and the concentration of total 
bilirubin. Moreover, administration of TQ at a dose of 
10 mg/kg protected the liver against sodium fluoride 
toxicity and improved its functioning as proven via the 
noteworthy decrease in these liver function 
biomarkers compared to the sodium fluoride group 
[24]. 
SOD, GPx is the major antioxidant enzyme-
reducing superoxide and this way antioxidant enzyme 
prevent the pathogenesis. In this study, it was 
observed that thymoquinone, significantly restore the 
antioxidant enzyme activity including SOD, GPx and 
catalase in CCl4 plus thymoquinone group as 
compared to the CCl4 treated (disease control group). 
The activity of the antioxidant enzymes SOD, GPx 
and catalase were significantly decreased in the 
disease control group (Group 2) as compared to the 
untreated control (Group 1) (Figure 3). An interesting 
study reported that lead exposure significantly 
decreased reduced glutathione level and superoxide 
dismutase, glutathione peroxidase, catalase, and 
glutathione reductase activities in the renal tissue. 
Remarkably, supplementation with TQ significantly 
improved the affected antioxidant parameters [25]. 
Another finding result revealed that in the 
acetaminophen + TQ group, the GPx activity was 
found to be significantly higher compared to the 
acetaminophen group [23]. 
Liver tissue alterations were noted in CCl4 
treated group, and it was severe congestion, 
infiltration of inflammatory cells, degeneration and 
blood vessel dilation. Though these consequences 
were also noticed in the CCl4 plus thymoquinone 
group, the severity of liver tissue alterations was less 
than those in the CCl4 treated group. Earlier findings 
demonstrated that subchronic ethanol exposure 
caused severe steatosis, central vein congestion, and 
infiltration of inflammatory factors in focal portal space 
in the liver [26]. In this regard, other results 
demonstrated that the gentamicin-induced liver 
histological alterations, such as hydropic degeneration 
of hepatocytes, fatty changes, inflammatory cell 
infiltration and congestion of portal vein were 
successfully recovered by thymoquinone and 
curcumin treatment [27]. This finding revealed that TQ 
has potential effect in normalisation of architecture of 
liver tissue damage by CCl4 induced hepatotoxicity. 
PTEN is located on chromosome 10 and 
tumour suppressor gene is located in the 10q23 
region encoding for a 403-amino acid multifunctional 
protein, which possesses lipid and protein 
phosphatase activities [28]. Additionally, the loss of 
PTEN gene expression causes abnormal activation of 
the PI3K/Akt and ERK pathways and, accordingly, 
leads to cancer cell proliferation and, finally, 
stimulates tumourigenesis [29]. In the current study, 
expression of PTEN protein was noted in all the 
animal groups. The intensity of the expression was 
high in the control group as well as in CCl4 plus 
thymoquinone treated group as compared to CCl4 
treated group. Additionally, loss of PTEN protein 
expression was noticed in CCl4 treated group as 
compared to control group as well as CCl4 plus 
thymoquinone group. An interesting study based on 
TQ reported that TQ induces apoptosis in doxorubicin-
resistant breast cancer cells through up-regulation of 
PTEN at transcription level and its treatment 
increased cellular levels of PTEN proteins, resulting in 
a significant decrease of phosphorylated Akt, a known 
regulator of cell survival [30].  
P53 remains the most frequently mutated 
gene in several common human cancers, with 
mutations estimated to occur in 50% of all types of 
cancers [31]. Altered expression of P53 has been 
noticed in several types of tumors. P53 expression 
was evaluated in all groups of mice and it was noticed 
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that all cases of control group did not show any 
expression. A higher expression of P53 protein was 
noticed in CCl4 treated group as compared to CCl4 
plus thymoquinone group. The difference in 
expression pattern among CCl4 treated group and 
thymoquinone plus CCl4 treated group was statically 
significant (p < 0.05). A recent study based on MCF-7 
breast cancer cells confirms that thymoquinone can 
induce apoptosis in MCF-7 breast cancer cells 
through the up-regulation of P53 expression [32]. 
Another study reported that P53 higher expression 
was noticed in CCl4 treated group as compared to 
control group and green tea extract (GTE) group. A 
supplementation of GTE with CCl4 induced a 
significant reduction of P53 level [33]. Another study 
based on curcumin reported that STZ exposure 
significantly increased P53 protein levels and CUR 
attenuated this activation [34].  
Vascular endothelial growth factor (VEGF) is 
a signalling protein that promotes the growth of new 
blood vessels. It is produced by several cell types 
including tumour cells [35], [36], macrophages 
[37] and its altered expression has been noticed in 
many tumours. In the current study, the control group 
showed weak cytoplasmic expression whereas 
expression was high in CCl4 treated group. Moreover, 
VEGF expression was also noted in thymoquinone 
plus CCl4 treated group. The difference in expression 
pattern between CCl4 treated group and CCl4 plus 
thymoquinone treated group was statically 
insignificant. Moreover, a finding demonstrated that 
administration of NAC (N-acetylcysteine) and ALA (α-
Lipoic acid) and THQ (Thymoquinone) either alone or 
in combination along with acetaminophen down 
regulates flat-1 (VEGFR1) expression [38]. 
The potential anticancer activity of the combination 
of thymoquinone (TQ) and resveratrol (RES) 
against breast cancer in mice was evaluated, and the 
results demonstrated that combination therapy 
enhanced apoptosis, and decreased VEGF 
expression [39].  
Understanding the mechanisms of apoptosis 
is crucial and helps in the understanding the 
pathogenesis of conditions as a result of disordered 
apoptosis [40]. Apoptotic bodies were not detected in 
any group including control, CCl4 treated as well as 
CCl4 plus thymoquinone treated group. In this regards, 
the previous study confirmed that apoptotic bodies 
were observed in cancer cases, while control cases 
did not show apoptosis [14]. 
In this study, a hepatotoxic agent such as 
CCl4 causes liver hepatotoxicity as evidenced by the 
increase of liver function enzymes and also causes 
liver tissue alteration including infiltration of 
inflammatory cells, fatty degeneration and blood 
vessel dilation. The mice treated with CCl4 plus 
thymoquinone shows role in the protection of the liver 
structure as the severity of fatty degeneration and 
blood vessel dilation and infiltration of inflammatory 
was less. Also, thymoquinone might play a role in 
restoring the liver antioxidant enzyme activity 
including SOD, GPx and Catalase. The intensity of 
PTEN expression was high well as in CCl4 plus 
thymoquinone treated the group as compared to CCl4 
treated group. A higher expression of P53 protein was 
noticed in CCl4 treated the group as compared to CCl4 
plus thymoquinone group and difference in expression 
pattern was statically significant. The protective effect 
of thymoquinone signifies a potentially preventive drug 
in the development of novel therapeutic agents for 
liver tissue alteration in the CCl4 hepatotoxicity.  
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